Clinical trial
Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That…
NCT00450372 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00450372 |
|---|---|
| Title | Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery |
| Official title | Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological, Other |
| Interventions | ADI-PEG-20, Pharmacology Studies |
| Enrollment | 38 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2011 |
| Completion | Feb 1, 2012 |
| First posted | Mar 22, 2007 |
| Last update posted | Feb 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: